SCHEMBL4068566

SCHEMBL4068566

CC(=O)Nc1nc(C)c(Br)cc1C#C[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
PIK3CG P48736 2/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DYRK1A Q13627 3/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GLA P06280 1/20 0.32
HIF1A Q16665 1/20 0.32
NPC1 O15118 1/20 0.31
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1564710 0.85 DYRK1A (0.32) ALDH1A1KDM4ESMN1; SMN2DYRK1ARAB9A
SCHEMBL1564798 0.85 IDO1 (0.33) ALDH1A1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL17221745 0.82 KDM4E (0.50) ALDH1A1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL4770176 0.80 GAA (0.47) ALDH1A1KDM4ESMN1; SMN2RAB9AKMT2A
SCHEMBL1516634 0.76 DYRK1A (0.36) ALDH1A1KDM4ESMN1; SMN2DYRK1ARAB9A
SCHEMBL4074467 0.71 LMNA (0.34) ALDH1A1KDM4ELMNAHSD17B10
SCHEMBL4771954 0.71 GAA (0.43) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL16246778 0.70 KDM4E (0.46) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL5818552 0.70 PRKD3 (0.40) ALDH1A1KDM4ESMN1; SMN2RAB9ALMNA
SCHEMBL18370146 0.69 IGF1R (0.31) DYRK1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306126-A1 Indole Derivatives ASTRAZENECA AB (SE) 2009-12-10 US disclosed
CN-101448827-A Indole derivatives ASTRAZENECA AB (SE) 2009-06-03 CN disclosed
EP-2029593-A1 INDOLE DERIVATIVES AstraZeneca AB (SE) 2009-03-04 EP disclosed
WO-2007135398-A1 INDOLE DERIVATIVES ASTRAZENECA AB (SE) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306126-A1 Indole Derivatives MTOR, IDO1, AKT1S1 ALDH1A1 1318/4885PIK3CG 32/4885PIK3CD 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.